Wells Fargo & Company »

Day One Biopharmaceuticals I shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $558k 38k 14.60
2023-09-30 $952k 78k 12.27
2023-06-30 $1.1M 91k 11.94
2022-12-31 $446k 21k 21.52
2022-09-30 $313k 21k 14.93
2022-06-30 $362k 20k 17.90
2022-03-31 $99k 10k 9.90
2021-12-31 $181k 11k 16.98
2021-09-30 $190k 10k 18.87